Xinyu Zhou Selected Research

Peptides (Polypeptides)

4/2022	Beneficial Effect of Kidney Bean Resistant Starch on Hyperlipidemia-Induced Acute Pancreatitis and Related Intestinal Barrier Damage in Rats.
1/2021	A novel surface-enhanced Raman scattering probe based on Au nanoboxes for dynamic monitoring of caspase-3 during cervical cancer cell apoptosis.
9/2017	Sustained Release of a Peptide-Based Matrix Metalloproteinase-2 Inhibitor to Attenuate Adverse Cardiac Remodeling and Improve Cardiac Function Following Myocardial Infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinyu Zhou Research Topics

Disease

26	Neoplasms (Cancer) 04/2024 - 03/2015
11	Major Depressive Disorder (Major Depressive Disorders) 04/2024 - 01/2016
9	Infections 03/2024 - 03/2014
8	Treatment-Resistant Depressive Disorder 01/2020 - 11/2014
7	Wounds and Injuries (Trauma) 01/2024 - 07/2014
7	Depressive Disorder (Melancholia) 01/2022 - 01/2015
6	Inflammation (Inflammations) 11/2023 - 01/2020
5	Ischemia 01/2023 - 04/2016
5	Hepatocellular Carcinoma (Hepatoma) 07/2022 - 08/2016
5	Hypoxia (Hypoxemia) 07/2022 - 07/2014
4	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2021
4	Fibrosis (Cirrhosis) 01/2024 - 01/2020
3	Myocardial Infarction 01/2022 - 09/2017
3	Body Weight (Weight, Body) 01/2021 - 05/2016
3	Triple Negative Breast Neoplasms 01/2021 - 09/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 08/2023
2	COVID-19 04/2024 - 11/2023
2	Disease Progression 03/2024 - 09/2021
2	Pain (Aches) 01/2024 - 01/2022
2	Rosacea (Acne Rosacea) 01/2024 - 01/2023
2	Asthma (Bronchial Asthma) 11/2023 - 09/2023
2	Obesity 11/2023 - 08/2022
2	Schizophrenia (Dementia Praecox) 11/2023 - 01/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2023 - 01/2023
2	Squamous Cell Carcinoma of Head and Neck 04/2023 - 08/2022
2	Carcinoma (Carcinomatosis) 01/2023 - 01/2020
2	Brain Injuries (Brain Injury) 01/2023 - 04/2016
2	Carcinogenesis 07/2022 - 08/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 12/2020
2	Malaria 02/2022 - 09/2020
2	Stroke (Strokes) 01/2022 - 01/2018
2	Anhedonia 01/2022 - 05/2016
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2022
2	Infarction (Infarctions) 01/2022 - 01/2018
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2020
2	Acute Lung Injury 01/2022 - 01/2021
2	Ischemic Stroke 01/2022 - 06/2021
2	Brain Ischemia (Cerebral Ischemia) 12/2021 - 09/2020
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 09/2020
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 09/2020
2	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2018
2	Corneal Injuries 01/2020 - 01/2019
2	Anxiety Disorders (Anxiety Disorder) 01/2018 - 10/2015
1	Erythema 05/2024
1	Acne Vulgaris 05/2024
1	Hyperpigmentation 05/2024
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2014
12	Antidepressive Agents (Antidepressants)IBA 01/2022 - 11/2014
11	Biomarkers (Surrogate Marker)IBA 04/2024 - 03/2014
5	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2021
4	Anti-Bacterial Agents (Antibiotics)IBA 06/2023 - 01/2019
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2015
4	Sucrose (Saccharose)IBA 01/2022 - 05/2016
3	Amino Acids FDA Link 04/2024 - 10/2022
3	LipidsIBA 10/2022 - 01/2022
3	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 01/2022
3	Peptides (Polypeptides)IBA 04/2022 - 09/2017
3	artemisinin (artemisinine)IBA 02/2022 - 09/2020
2	Nitrous Oxide (Laughing Gas)IBA 11/2023 - 01/2023
2	CollagenIBA 04/2023 - 10/2015
2	Cytochromes c (Cytochrome c)IBA 04/2023 - 12/2020
2	Caspase 3 (Caspase-3)IBA 04/2023 - 01/2021
2	Long Noncoding RNAIBA 01/2023 - 12/2021
2	Irritants (Vesicants)IBA 01/2023 - 01/2022
2	Antiviral Agents (Antivirals)IBA 07/2022 - 04/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 10/2021
2	AntioxidantsIBA 01/2022 - 01/2022
2	artenimol (dihydroartemisinin)IBA 01/2021 - 09/2020
2	Glutamic Acid (Glutamate)FDA Link 08/2020 - 01/2019
2	InterferonsIBA 04/2020 - 01/2020
2	Oxygen (Dioxygen)IBA 01/2018 - 01/2017
2	Antipsychotic Agents (Antipsychotics)IBA 05/2015 - 11/2014
2	Pindolol (LB 46)FDA LinkGeneric 05/2015 - 04/2015
1	Hemoglobins (Hemoglobin)IBA 05/2024
1	azelaic acid (Azelex)FDA Link 05/2024
1	Melanins (Melanin)IBA 05/2024
1	Calcium-Binding ProteinsIBA 04/2024
1	S100 Proteins (S 100 Protein)IBA 04/2024
1	polyphyllin IIBA 04/2024
1	VaccinesIBA 04/2024
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2024
1	2- amino- 3- (4- ((5- amino- 2- phenylbenzo(d)oxazol- 7- yl)methoxy)- 3,5- dichlorophenyl)propanoic acidIBA 03/2024
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 03/2024
1	Cyclin D1IBA 03/2024
1	Neutral Amino AcidsIBA 03/2024
1	Large Neutral Amino Acid-Transporter 1IBA 03/2024
1	Celecoxib (Celebrex)FDA Link 01/2024
1	Dinoprostone (PGE2)FDA Link 01/2024
1	Toll-Like Receptor 3IBA 01/2024
1	Deoxyribonuclease I (Nickase)IBA 01/2024
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2024
1	Arginine (L-Arginine)FDA Link 01/2024

Therapy/Procedure

21	Therapeutics 11/2023 - 04/2015
5	Immunotherapy 04/2024 - 01/2023
4	Intravenous Administration 01/2024 - 04/2016
4	Drug Therapy (Chemotherapy) 01/2022 - 09/2018
2	Electroacupuncture 01/2022 - 01/2022
2	Duration of Therapy 01/2020 - 08/2016
1	Blood Transfusion (Blood Transfusions) 01/2024